ArticleCell death and differentiation2022

Loss of RBMS1 promotes anti-tumor immunity through enabling PD-L1 checkpoint blockade in triple-negative breast cancer.

Jinrui Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.